When Should Neurologists Discontinue Disease-Modifying Treatments in Patients With MS?June 22, 2017Multiple Sclerosis
Disease-Modifying Drug Treatment Before, During, and After Pregnancy in Women With MSJune 5, 2017Multiple Sclerosis
Alemtuzumab May Prevent MRI Lesions for Six Years in Patients With Highly Active DiseaseMay 31, 2017Multiple Sclerosis
Siponimod Reduces Risk of Confirmed Disability Progression in Secondary Progressive MS May 31, 2017Multiple Sclerosis
Should Patients on B Cell–Depleting Therapies Be Immunized Against Influenza?May 26, 2017Multiple Sclerosis
